Orca Biosystems Inc.

1 FDA products 1 active ingredients CELLULAR THERAPY

Orca Biosystems Inc. is listed as the manufacturer on 1 FDA drug label records covering 1 distinct active ingredients predominantly cellular therapy products.

About Orca Biosystems Inc.

Orca Biosystems Inc. is named as the labeler on 1 FDA drug label records. Its catalogue spans 1 distinct active ingredients, led by ALLOGENEIC REGULATORY T CELL IMMUNOTHERAPY WITH HSPC AND T CELLS-VLDQ. Most of these labels are cellular therapy products. Labelling across this portfolio most often references: hematopoietic stem, matched donor, cell transplantation, myeloablative preparative, immunologic reconstitution, improve chronic, treatment adults, hematological malignancies. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.

Active ingredients in this portfolio

FDA drug products from Orca Biosystems Inc.

Brand nameGenericTypeRoute
TREGZI ALLOGENEIC REGULATORY T CELL IMMUNOTHERAPY WITH HSPC AND T CELLS-VLDQ CELLULAR THERAPY

Frequently asked questions

How many FDA drug products does Orca Biosystems Inc. make?
1 FDA drug label records name Orca Biosystems Inc. as the manufacturer, covering 1 distinct active ingredients.

What active ingredients does Orca Biosystems Inc. produce?
The most frequent active ingredients in this portfolio are ALLOGENEIC REGULATORY T CELL IMMUNOTHERAPY WITH HSPC AND T CELLS-VLDQ.

Are Orca Biosystems Inc. products prescription or over-the-counter?
The largest share of this company’s labels are cellular therapy products; check each product page for its own marketing status.

Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.

Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.